• 1. Department of Thoracic Surgery, Peking University Third Hospital, Beijing, 100191, P. R. China;
  • 2. The First Clinical Medical College, Nanjing Medical University, Nanjing, 211103, P. R. China;
  • 3. China-Japan Friendship Institute of Clinical Medicine, Beijing, 100029, P. R. China;
QIANG Guangliang, Email: pkudd@126.com
Export PDF Favorites Scan Get Citation

Since the outbreak of COVID-19 pandemic, a large number of elective or limited operations, including tumor treatment, have been postponed. With the deepening of the understanding of the virus and the change of the prevention policy, the impact of the pandemic is gradually shrinking, and a large number of operations delayed by the pandemic will be rescheduled. However, there is no consensus on the best time to perform surgery for patients infected with SARS-CoV-2, and the consensus on thoracic surgery is more limited. This article reviews the research progress in the timing of surgical operations, especially thoracic surgery, after SARS-CoV-2 infection.

Citation: NING Yingze, NI Yihong, CHEN Fangjun, QIANG Guangliang. Research progress in the timing of thoracic surgery after SARS-CoV-2 infection. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2023, 30(3): 344-349. doi: 10.7507/1007-4848.202301030 Copy

  • Previous Article

    Efficacy and safety of video-assisted anal fistula treatment compared with incision and thread drawing in the treatment of complex anal fistula: a meta-analysis
  • Next Article

    地塞米松联合用药方案在原发性甲状腺功能亢进患者术前准备中的临床实践经验